New SEC Form D filing
Dvant Pharma, Inc., 2026-10-13
A new SEC Form D private-offering notice from Superior Township, MI, a $3,090,400 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Dvant Pharma, Inc. Verified via SEC Form D
Biotech developing EGFR degrader therapies for solid tumors, based on University of Michigan oncology research
Filed 2026-10-13Filed to raise $3,090,400First money in 2026-09-29Raised so far $1,230,400HQ (as filed) Superior Township, MISector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- StrikeArc Labs Inc., 2026-10-16, $500K, Birmingham, MI
- Hypercell Technologies Inc., 2026-10-14, $4.4M, Ithaca, NY
- Motaris Inc., 2026-10-16, $300K, Ann Arbor, MI
- Tempest Therapeutics, Inc., 2026-10-14, $7.5M, Brisbane, CA
- Pyropic, Inc., 2026-10-07, $2M, Ann Arbor, MI
- Spiritus, Inc., 2026-10-13, $68K, Milwaukie, OR
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.